Patterson Companies Reports Fiscal 2014 Fourth Quarter Operating Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Patterson Companies, Inc. (Nasdaq: PDCO) today reported that consolidated sales totaled $1.1 billion in its fiscal fourth quarter ended April 26, 2014, an increase of 14.2 percent from $964.9 million in the year-earlier period. Net income was $61.4 million, or $0.61 per diluted share (excluding costs related to the Medical unit restructuring), versus net income of $63.6 million, or $0.62 per diluted share, in the year-ago period.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC